Aspirin resistance and its implications in clinical practice - Wikidata - awgldk - TriplyDB

Aspirin resistance and its implications in clinical practice

Aspirin resistance and its implications in clinical practice

http://www.wikidata.org/entity/Q28194069

about

Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis.

P2860

Q55473805-36041BE0-3034-4265-B911-3EDBD4526CF0

P2860

Aspirin resistance and its implications in clinical practice

http://www.wikidata.org/entity/Q28194069

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Aspirin resistance and its implications in clinical practice

@ast

Aspirin resistance and its implications in clinical practice

@en

Aspirin resistance and its implications in clinical practice

@nl

type

label

Aspirin resistance and its implications in clinical practice

@ast

Aspirin resistance and its implications in clinical practice

@en

Aspirin resistance and its implications in clinical practice

@nl

prefLabel

Aspirin resistance and its implications in clinical practice

@ast

Aspirin resistance and its implications in clinical practice

@en

Aspirin resistance and its implications in clinical practice

@nl

P1433

Q28194069-FF82E104-D858-4CC8-B462-F5D0DBA2987E

P1476

Q28194069-BC9213F4-54B9-405E-B37C-FCCAAA1C39DC

P2093

Q28194069-238779B1-8B23-4E1A-B3F2-646D564A49A9

Q28194069-5A9A31E6-9C43-406A-BE06-308BBD1ECC9E

Q28194069-6CF5EB11-98B8-43D2-A1DB-CE1362FBE5BA

Q28194069-759BE75A-3894-4CAB-8FA6-C265CF535DEB

P2860

Q28194069-1EBD54E3-B48E-4992-9913-6137D110CA83

Q28194069-246E96F4-D211-4833-8402-66873DC4FF2A

Q28194069-28E0F440-B6A9-4B09-AD46-EC28A642FD00

Q28194069-403F8E1E-2452-4E95-BEDC-33FEB8B314BB

Q28194069-439FF6DC-F1FE-4220-9529-45B0A9B3FF96

Q28194069-79925A78-6C6F-42BF-8C08-DF8BDF992DB4

Q28194069-97378822-A4F4-414D-BD1C-3D5D6AA0F6EF

Q28194069-9A98535D-EC1E-4D11-A376-3E9AA39B05E5

Q28194069-A1A9F163-C505-4836-B54B-597D6C812090

Q28194069-A21DED88-260E-40A3-ADB7-5204DDEB51E1

P304

Q28194069-E5AD031A-F228-4DD8-8265-FA8E23081C14

P31

Q28194069-A27E2390-2750-48CD-A41F-A420DB8C3EB3

P407

Q28194069-95ED0AB4-2048-4BB5-AD7E-CC4E6D14D77B

P433

Q28194069-7A672AEC-B5A2-47DD-84CB-B6FBFAE0AD01

P478

Q28194069-B1F98852-E073-4549-9516-32E22E4A7A29

P50

Q28194069-7FEAE459-C1E7-4DE5-B5E7-745CAD6F9617

Q28194069-9B875305-2097-4DCF-B607-7C9A342B2CD5

P577

Q28194069-3AD8AC7D-FFDE-4B73-89EA-64AEEE926608

P698

Q28194069-5E26D951-7042-4034-BCA6-CCAC0FE856AD

P921

Q28194069-2BFA7BE0-22A1-4D5B-8D57-E7EE6B2728C6

P932

Q28194069-A13110E0-CEF4-4FF5-ACBC-BA094B48DC2A

P1433

MedGenMed : Medscape general medicine

P1476

Aspirin resistance and its implications in clinical practice

@en

P2093

Alan D Michelson

http://www.w3.org/2001/XMLSchema#string

John A Oates

http://www.w3.org/2001/XMLSchema#string

Mark Feldman

http://www.w3.org/2001/XMLSchema#string

Shamir R Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

Platelet function testing in cardiovascular diseases

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Aspirin non-responder status in patients with recurrent cerebral ischemic attacks

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

P304

76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

John W. Eikelboom

P577

2005-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16369302

http://www.w3.org/2001/XMLSchema#string

P921

P932

1681651

http://www.w3.org/2001/XMLSchema#string